Previous 10 | Next 10 |
2024-02-23 15:00:00 ET More on the markets SPDR S&P 500 ETF And Invesco QQQ Trust: Almost All Investors Are Crowded Into The Same Side Of The Boat SPY: The U.S. Is Positioned To Expand Its Global Dominance S&P 500: Correction In Progress, Deeper Selloff Expec...
2024-02-23 06:14:00 ET With shares of Iovance Biotherapeutics (NASDAQ: IOVA) soaring by 175% in the last three months, Wells Fargo analyst Yanan Zhu thinks they could still go as much as 47% higher. In fact, on Feb. 20, the analyst raised his price target for the stock from $17 ...
2024-02-23 00:04:26 ET Summary On February 16, the Food and Drug Administration granted an accelerated approval to Iovance Biotherapeutics' lifileucel or Amtagvi. This accelerated approval would make Amtagvi the first T-cell therapy for treating a solid tumor. I take a close l...
A look at the top 10 most actives in the United States Greenbrook TMS Inc. (GBNH) rose 64.9% to $0.32 on volume of 109,974,769 shares PROSHARES TRUST (SQQQ) rose 3.7% to $12.36 on volume of 106,443,308 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 4.7% to $4.825 on volume...
2024-02-21 13:09:13 ET DENVER, Colo., Feb 21, 2024 (www.247marketnews.com)- Midday Stocks to Watch; (NASDAQ: BREA ), (NASDAQ: VTYX ), (NYSE: WTTR ), (NASDAQ: IOVA ), (NASDAQ: EBS ) News Brera Holdings’ Strategic Victory: A Leap Forward for Mozambiq...
2024-02-21 11:42:05 ET DENVER, Colo., Feb 21, 2024 (www.247marketnews.com)- Iovance Biotherapeutics (NASDAQ: IOVA ) continues to press forward on the strength of the U.S. Food and Drug Administration (FDA) approving its AMTAGVI (lifileucel) suspension for intravenous infusion, on F...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is one today's most active stocks by volume. So far today, approximately 27.57M shares of Iovance Biotherapeutics, Inc. have been exchanged, as compared to an average 30-day volume of 11.12M shares. Iovance Biotherapeutics, Inc., a clinical-stage bi...
2024-02-20 12:50:54 ET Gainers: Pop Culture Group Co Ltd ( CPOP ) +176% . AgriFORCE Growing Systems ltd ( AGRI ) +95% . Trxade Health ( MEDS ) +92% . Intuitive Machines ( LUNR ) +48% . Iovance Biotherapeutics ( IOVA ) +39% . ...
2024-02-20 11:11:17 ET More on Iovance Biotherapeutics Iovance Biotherapeutics: Amtagvi's Pioneering Approval Sets New Standards In Melanoma Iovance: Approval For Historic Solid Tumor Targeting TIL Therapy Likely, Outlook Promising Iovance Biotherapeutics: Preparing ...
2024-02-20 11:02:33 ET Shares of Iovance Biotherapeutics (NASDAQ: IOVA) had skyrocketed by 33.8% as of 10:39 a.m. ET Tuesday. The huge gain came after the company announced on Friday that the Food and Drug Administration (FDA) had granted accelerated approval for Amtagvi (lefileucel...
News, Short Squeeze, Breakout and More Instantly...
Iovance Biotherapeutics Inc. Company Name:
IOVA Stock Symbol:
NASDAQ Market:
Iovance Biotherapeutics Inc. Website:
First of Multiple Planned Global Submissions for Lifileucel in 2024 and 2025 Key Step in Global Expansion to Address >20,000 Patients Annually with Previously Treated Advanced Melanoma SAN CARLOS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, In...
2024-06-28 04:05:00 ET Earlier this year, share prices of Iovance Biotherapeutics (NASDAQ: IOVA) were soaring after one of its therapies obtained approval from regulators. Iovance stock would go on to reach share price highs of more than $18. Today, however, the stock trades at less...
2024-06-20 07:00:08 ET Reni Benjamin from JMP Securities issued a price target of $23.00 for IOVA on 2024-06-20 06:20:00. The adjusted price target was set to $23.00. At the time of the announcement, IOVA was trading at $8. The overall price target consensus is at $23.83...